Tenet Healthcare THC
United StatesHealthcare · Medical Care FacilitiesUSD
285.32 USD (+9.8%)
22 analysts
Trading 2120.30 €Open account ↗
Lightyear0.90 €Open account ↗
N260.90 €Open account ↗
XTB1.00 €★ featured · affiliateOpen account ↗Trading 2120.30 €Open account ↗Lightyear0.90 €Open account ↗XTB1.00 €★ featured · affiliateOpen account ↗200.00 € order · cheapest cheapest available in your country iCompare all 22 brokers →What does it do?
Tenet Healthcare is a hospital and health center operator in the United States, providing medical and surgical services through its network of facilities.
Key points
from its scores- ✓Good share-price trend8.8
- ✓Strong growth8.0
- ✓Attractive valuation7.7
- ✕Little or no dividend1.5
- ✕Unfavourable risk and backdrop4.8
AI analysis
bottom line, main risk, context and newsSolid cash generation and attractive valuation offer a good risk/reward profile.
Tenet Healthcare shows solid financial health (ND/EBITDA 2.29, operating margin 18.16%) and exceptional profitability (ROE 37.34%, ROIC 22.12%). Its valuation is attractive (P/E 10.08) and earnings growth is very strong (213.4%), although the dividend is non-existent.
The main risk is exposure to regulatory and reimbursement changes in the US healthcare sector, which could compress operating margins.
Context and risks
Tenet operates in the US hospital sector, subject to constant regulatory and reimbursement scrutiny from Medicare and Medicaid. Changes in reimbursement policies or competition laws can directly affect its margins. Furthermore, its business depends on healthcare regulation, adding a moderate governance risk.
Is Tenet Healthcare stock cheap or expensive?
at the analysis dateOn P/E and EV / EBITDA, it trades 55% below the Healthcare median on average.
| Multiple | Company | Sector | Difference |
|---|---|---|---|
| P/E | 10.1 | 26.7 | −62% |
| EV / EBITDA | 7.4 | 14.5 | −49% |
| Price / book | 4.5 | 4.1 | +9% |
| Price / sales | 1.0 | 3.4 | −72% |
Sector: median of the 217 Healthcare companies analysed. In bold, the multiples used for the comparison.
Valuation score: 7.7 out of 10 (median for Healthcare: 4.7).
Average analyst target: 285.32 USD, +9.8% versus the price.
A discount may reflect more risk or slower growth than its sector: Financial health 6.4 (sector 6.5), Growth 8.0 (sector 6.6).
Classic formulas with standard assumptions (0.0% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.
Work out its fair value yourself →How much would you have made investing every month? →
Comparing it with its sector does not say whether it is a good buy: this is not investment advice.
Score by category
0 to 10 · hover overtap each one to see what it measuresKey metrics
at the analysis date · compared with the Healthcare medianValuation
- P/E
- 10.1
- Forward P/E
- 12.3
- EV / EBITDA
- 7.4
- Price / book
- 4.5
- Price / sales
- 1.0
- PEG
- 1.79
- Market cap
- 20.9B USD
- Enterprise value
- 36.0B USD
Profitability
- ROE
- 37.3%
- ROA
- 8.3%
- ROIC (approx.)
- 22.1%
- Gross margin
- 41.7%
- Operating margin
- 18.2%
- Net margin
- 10.3%
- Free cash flow
- 2.2B USD
- FCF yield
- 10.7%
- Cash conversion
- 46%
Solvency
- Total debt
- 13.2B USD
- Net debt
- 11.1B USD
- Cash
- 2.2B USD
- EBITDA
- 4.8B USD
- Net debt / EBITDA
- 2.29
- Debt / equity
- 152.28
- Current ratio
- 1.41
- Quick ratio
- 1.15
Growth
- Revenue growth
- +6.8%
- Earnings growth
- +213.4%
- EPS (TTM)
- 25.78 USD
- EPS (forward)
- 21.08 USD
Dividend
- Dividend yield
- 0.0%
- Payout
- 0.0%
Risk and market
- Beta
- 1.20
- Analyst consensus
- Buy (22)
- Target price
- 285.32 USD
- 52-week range
- 157.58 – 283.05
Recent news
All THC news →Compare it with its sector
All 217 in Healthcare →Frequently asked questions about Tenet Healthcare
Is Tenet Healthcare stock cheap or expensive?
On P/E and EV / EBITDA, it trades 55% below the Healthcare median on average. Valuation score: 7.7 out of 10 (median for Healthcare: 4.7). Average analyst target: 285.32 USD, +9.8% versus the price. This is not investment advice.
What score does Tenet Healthcare get on MeridIAn Screener?
It scores 6.7 out of 10, rank 412 of 2,130 (better than 80% of the companies analysed). Its strongest category is Momentum (8.8) and its weakest, Dividend (1.5). Analysis of 08/10/2026.
What is Tenet Healthcare's P/E ratio?
Its P/E is 10.1: the share price equals 10.1 times earnings per share over the last 12 months. The Healthcare median is 26.7. Based on the earnings analysts expect, the forward P/E is 12.3.
How much is Tenet Healthcare worth on the stock market?
Its market capitalisation is 20.9B USD and its enterprise value, debt included, is 36.0B USD.
How much debt does Tenet Healthcare have?
Its net debt (debt minus cash) is 11.1B USD. That is 2.29 times its EBITDA; the Healthcare median is 1.53.
Does Tenet Healthcare pay a dividend?
It pays no dividend, or almost none.
How has Tenet Healthcare stock performed over the last year?
It has risen 37.1% over the last year, excluding dividends. Over the last 52 weeks it has traded between 157.58 and 283.05 USD. Past performance does not guarantee future results.
What do analysts think of Tenet Healthcare?
22 analysts cover it; their average recommendation is “Buy” and their average target is 285.32 USD (+9.8% versus the price). It is an estimate, not market data.